Shares of Cognyte Software Ltd. (NASDAQ:CGNT - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $8.41, but opened at $7.80. Cognyte Software shares last traded at $7.60, with a volume of 507,574 shares changing hands.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on CGNT shares. StockNews.com downgraded Cognyte Software from a "strong-buy" rating to a "buy" rating in a report on Thursday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cognyte Software in a report on Tuesday.
View Our Latest Stock Analysis on CGNT
Cognyte Software Stock Performance
The company has a market cap of $500.47 million, a price-to-earnings ratio of -12.27 and a beta of 1.68. The company has a fifty day moving average of $7.60 and a two-hundred day moving average of $6.08.
Institutional Investors Weigh In On Cognyte Software
Several hedge funds have recently modified their holdings of the company. Quadrature Capital Ltd acquired a new stake in shares of Cognyte Software during the 4th quarter valued at $144,000. Goldman Sachs Group Inc. boosted its holdings in shares of Cognyte Software by 18.3% during the 4th quarter. Goldman Sachs Group Inc. now owns 313,731 shares of the medical device company's stock valued at $2,017,000 after acquiring an additional 48,595 shares in the last quarter. Virtu Financial LLC bought a new position in Cognyte Software during the 4th quarter worth $167,000. Legal & General Group Plc raised its position in Cognyte Software by 5.9% during the 4th quarter. Legal & General Group Plc now owns 4,033,757 shares of the medical device company's stock worth $25,937,000 after purchasing an additional 224,801 shares during the last quarter. Finally, G2 Investment Partners Management LLC raised its position in Cognyte Software by 241.5% during the 4th quarter. G2 Investment Partners Management LLC now owns 1,366,163 shares of the medical device company's stock worth $8,784,000 after purchasing an additional 966,163 shares during the last quarter. Institutional investors and hedge funds own 72.92% of the company's stock.
Cognyte Software Company Profile
(
Get Free Report)
Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions.
Read More
Before you consider Cognyte Software, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognyte Software wasn't on the list.
While Cognyte Software currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
